{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-056425","form_type":"8-K","ticker":"IRD","cik":"0001228627","company_name":"Opus Genetics, Inc.","filed_at":"2023-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.463266+00:00","generated_at":"2026-06-07T16:53:02.588372+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Ocuphire promotes Ronil Patel to Chief Business Officer; grants 74K options and 50K RSUs","bullets":["Ronil Patel, age 40, promoted to Chief Business Officer effective December 1, 2023; previously SVP of Operations and Business Development.","Base salary set at $350,000, increasing to $400,000 upon meeting certain milestones (e.g., $100M cash balance or strategic term sheet).","Eligible for annual bonus targeted at 45% of base salary (up from 40%).","Granted incentive stock option to purchase 74,538 shares and RSU for 49,692 shares, vesting over ~2.5 years.","Background: 15 years experience; involved in deals over $300M; previously at Point Guard Partners."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-056425","json":"https://secwatch.observer/filing/0001140361-23-056425.json","markdown":"https://secwatch.observer/filing/0001140361-23-056425.md","text":"https://secwatch.observer/filing/0001140361-23-056425.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123056425/0001140361-23-056425-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123056425/ef20015996_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T16:53:02.588372+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0abbd1f59c","claim":"Ronil Patel changed role as Chief Business Officer at Opus Genetics, Inc..","evidence_excerpt":"On December 1, 2023, the Board of Directors (the \"Board\" ) of Ocuphire Pharma, Inc. (the \"Company\" ) promoted Ronil Patel , age 40, as the Company’s Chief Business Officer, effective as of December 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123056425/0001140361-23-056425-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}